Autoimmunity gene expression portrait: Specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus

Clinical and Experimental Immunology

Volumn 138, Issue 1, 2004, Pages 164-170

  Mandel, M ^a   Gurevich, M ^a   Pauzner, R ^a   Kaminski, N ^b   Achiron, A ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmunity; Gene expression; Multiple sclerosis; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL ADHESION MOLECULE; HEAT SHOCK PROTEIN; MATRIX METALLOPROTEINASE; RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA MICROARRAY; DNA REPAIR; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDBACK SYSTEM; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOGENETICS; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RELAPSING REMITTING MULTIPLE SCLEROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TIMP1 GENE;

ADULT; ANTIBODY FORMATION; APOPTOSIS; AUTOIMMUNITY; CELL DIVISION; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MATRIX METALLOPROTEINASES; MULTIPLE SCLEROSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 4644343950     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02587.x     Document Type: Article

References (36)

1. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84:223-43.
2. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs, Nat Med 2001; 7:899-905.
3. Salaman MR. A two-step hypothesis for the appearance of autoimmune disease. Autoimmunity 2003; 36:57-61.
4. Prat A, Biernacki K, Lavoie JF, Poirier J, Duquette P, Antel JP. Migration of multiple sclerosis lymphocytes through brain endothelium. Arch Neurol 2002; 59:391-7.
5. Yasutomo K. Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus. Rheumatology 2003; 42:214-22.
6. Maas K, Chan S, Parker J, Slater A, Moore J, Olsen N, Aune TM. Cutting edge: molecular portrait of human autoimmune disease. J Immunol 2002; 169:5-9.
7. Achiron A, Gurevich M, Friedman N, Kaminski N, Mandel M. Blood Transcriptional Signatures of Multiple Sclerosis: Unique gene expression of disease activity. Ann Neurol 2004; 55:410-7.
8. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001; 98:31-6.
9. Kaminski N, Friedman N. Practical approaches to analyzing results of microarray experiments. Am J Respir Cell Mol Biol 2002; 27:125-32.
10. Ben Dor L, Bruhn L, Friedman N, Nachman I, Schummer M, Yakhini Z. Tissue classification with gene expression profiles. J Comput Biol 2000; 7:559-83.
11. Rathmell JC, Thompson CB. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 2002; 109 (Suppl.):97-107.
12. Curtis DJ, Hilton DJ, Roberts B, Murray L, Nicola N, Begley CG. Recombinant soluble interleukin-11 (IL-11) receptor alpha-chain can act as an IL-11 antagonist. Blood 1997; 90:4403-12.
13. Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992; 256:105-7.
14. Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 1997; 186:1923-31.
15. Sato S, Ono N, Steeber DA, Pisetsky DS, Tedder TF. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J Immunol 1996; 157:4371-8.
16. Sato S, Hasegawa M, Fujimoto M, Tedder TF, Takehara K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 2000; 165:6635-43.
17. Rouault JP, Rimokh R, Tessa C et al. BTG1, a member of a new family of antiproliferative genes. EMBO J 1992; 11:1663-70.
18. Zucker S, Hymowitz M, Conner C et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci 1999; 878:212-27.
19. Bomprezzi R, Ringnér M, Kim S et al. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet 2003; 12:2191-9.
20. Chandler S, Miller KM, Clements JM, Lury J, Corkill D, Anthony DC, Adams SE, Gearing AJ. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol 1997; 72:155-61.
21. Faber E, Sthoeger Z, Tcherniack A, Dayan M, Mozes E. Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus. Clin Exp Immunol 2002; 127:393-8.
22. Botelho FM, Edwards DR, Richards CD. Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter. J Biol Chem 1998; 273:5211-8.
23. Zeng G, McCue HM, Mastrangelo L, Millis AJ. Endogenous TGF-beta activity is modified during cellular aging, effects on metalloproteinase and TIMP-1 expression. Exp Cell Res 1996; 228:271-6.
24. Waubant E, Gee L, Miller K, Stabler G, Goodkin D. IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis. J Interferon Cytokine Res 2001; 21:181-5.
25. Rechsteiner M, Realini C, Ustrell V. The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochem J 2000; 345 Part 1:1-15.
26. Zang YC, Hong J, Rivera VM, Killian J, Zhang JZ. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination. J Immunol 2000; 164:4011-7.
27. Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 2000; 288:675-8.
28. Bai XF, Liu JQ, Liu X, Guo Y, Cox K, Wen J, Zheng P, Liu Y. The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis. J Clin Invest 2000; 105:1227-32.
29. Zhou Q, Rammohan K, Lin S et al. CD24 is a genetic modifier for risk and progression of multiple sclerosis. PNAS 2003; 100:15041-6.
30. Strathdee CA, Duncan AM, Buchwald M. Evidence for at least four Fanconi anaemia genes including FANCC on chromosome 9. Nat Genet 1992; 1:196-8.
31. Larsen AK, Escargueil AE, Skladanowski A. From DNA damage to G2 arrest: the many roles of topoisomerase II. Prog Cell Cycle Res 2003; 5:295-300.
32. Dawson MJ, Trapani JA. The interferon-inducible autoantigen, IFI 16. localization to the nucleolus and identification of a DNA-binding domain. Biochem Biophys Res Commun 1995; 214:152-62.
33. Seelig HP, Ehrfeld H, Renz M. Interferon-gamma-inducible protein p16. A new target of antinuclear antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37:1672-83.
34. Kyaw H, Zeng Z, Su K, Fan P, Shell BK, Carter KC, Li Y. Cloning, characterization, and mapping of human homolog of mouse T-cell death-associated gene. DNA Cell Biol 1998; 17:493-500.
35. Tosa N, Murakami M, Jia WY et al. Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. Int Immunol 2003; 15:741-9.
36. Baechler EC, Batliwalla FM, Karypis G et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100:2610-5.